Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 1

Interventions

Specimen Handling 65Magnetic Resonance Spectroscopy 44Cyclophosphamide 32Carboplatin 31Gemcitabine 30Biopsy 28Cisplatin 25Bevacizumab 25Radiotherapy 24pembrolizumab 23Paclitaxel 23Standard of Care 22Oxaliplatin 22fludarabine 21Nivolumab 21Drug Therapy 21Capecitabine 21venetoclax 20Interviews as Topic 18Injections 17Radiosurgery 16Blood Specimen Collection 16toripalimab 15cemiplimab 15Dexamethasone 15Azacitidine 15tislelizumab 14Irinotecan 14Docetaxel 14anlotinib 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × efineptakin alfa × 90 days × Clear all
NCT07200089 2026-04-07

Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel)

Washington University School of Medicine

Phase 1 Not yet recruiting
52 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡